{"id":22861,"date":"2023-06-06T13:26:49","date_gmt":"2023-06-06T20:26:49","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=22861"},"modified":"2024-07-02T08:47:06","modified_gmt":"2024-07-02T15:47:06","slug":"guillain-barre-syndrome-vs-myasthenia-gravis","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/","title":{"rendered":"S\u00edndrome de Guillain-Barr\u00e9 vs. Miastenia Gravis"},"content":{"rendered":"<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/gbs-guillain-barre-syndrome\/\">S\u00edndrome de Guillain-Barr\u00e9<\/a> (GBS) y <a href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/myasthenia-gravis\/\">miastenia gravis<\/a> (MG) son trastornos neurol\u00f3gicos autoinmunes que se producen cuando el sistema inmunitario ataca c\u00e9lulas sanas, como nervios y m\u00fasculos. Tanto el SGB como la MG son afecciones graves, pero poco frecuentes, que pueden causar importantes discapacidades f\u00edsicas e incluso complicaciones potencialmente mortales si no se tratan. Si bien ambas enfermedades comparten algunas similitudes, como debilidad muscular y fatiga, los mecanismos subyacentes, la poblaci\u00f3n afectada, los s\u00edntomas, el inicio, la progresi\u00f3n y los enfoques de tratamiento difieren significativamente.\u00a0<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-37c3de86b58fc3d2bbc65b710bdc6928\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista \t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">En este art\u00edculo, explicaremos las diferencias clave entre el s\u00edndrome de Guillain-Barr\u00e9 y la miastenia gravis (MG), y los tratamientos disponibles para controlar los s\u00edntomas de estos trastornos neurol\u00f3gicos.<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#Guillain-Barre_Syndrome_vs_Myasthenia_Gravis_Key_Differences\" >S\u00edndrome de Guillain-Barr\u00e9 vs. Miastenia Gravis: Diferencias Clave<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#Underlying_Mechanism\" >Mecanismo subyacente<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#Symptoms_of_Guillain-Barre_Syndrome_vs_Myasthenia_Gravis\" >S\u00edntomas del s\u00edndrome de Guillain-Barr\u00e9 vs. miastenia grave<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#Susceptible_Population\" >Poblaci\u00f3n Susceptible<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#Onset_and_Progression\" >Inicio y progresi\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#Factors_That_Trigger_GBS_and_MG\" >Factores que desencadenan el s\u00edndrome de Guillain-Barr\u00e9 y la miastenia gravis (MG)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#Treatment_Options_for_Guillain-Barre_Syndrome_vs_Myasthenia_Gravis\" >Opciones de tratamiento para el s\u00edndrome de Guillain-Barr\u00e9 frente a la miastenia grave<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Guillain-Barre_Syndrome_vs_Myasthenia_Gravis_Key_Differences\"><\/span>S\u00edndrome de Guillain-Barr\u00e9 vs. Miastenia Gravis: Diferencias Clave<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Underlying_Mechanism\"><\/span><b>Mecanismo subyacente<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">El s\u00edndrome de Guillain-Barr\u00e9 se debe a que el sistema inmunitario ataca los nervios perif\u00e9ricos, ubicados fuera del cerebro y que controlan el movimiento y la sensibilidad. El sistema inmunitario produce anticuerpos que atacan por error la vaina de mielina (la capa protectora que rodea los nervios) o las propias fibras nerviosas, lo que provoca da\u00f1o e inflamaci\u00f3n nerviosa. Este da\u00f1o interrumpe la transmisi\u00f3n de se\u00f1ales del cerebro a los m\u00fasculos y provoca debilidad muscular y par\u00e1lisis.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La miastenia gravis tambi\u00e9n es causada por un ataque del sistema inmunitario. A diferencia del SGB, en la MG, el sistema inmunitario ataca las uniones neuromusculares, que son los puntos donde las c\u00e9lulas nerviosas se conectan con los m\u00fasculos. Normalmente, las c\u00e9lulas nerviosas liberan... <a href=\"https:\/\/my.clevelandclinic.org\/health\/articles\/24568-acetylcholine-ach#:~:text=Acetylcholine%20(ACh)%20is%20a%20neurotransmitter,%E2%80%9Cfire%20off%20the%20message.%E2%80%9D\">acetilcolina<\/a> (un neurotransmisor) que se une a su receptor en las fibras musculares. La uni\u00f3n de la acetilcolina a sus receptores provoca la contracci\u00f3n muscular y el movimiento. Sin embargo, en personas con MG, el sistema inmunitario produce anticuerpos que destruyen o bloquean estos receptores en las fibras musculares e impiden que reciban se\u00f1ales nerviosas (acetilcolina). Esto provoca debilidad muscular y fatiga debido a la alteraci\u00f3n de las contracciones musculares.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Symptoms_of_Guillain-Barre_Syndrome_vs_Myasthenia_Gravis\"><\/span><b>S\u00edntomas del s\u00edndrome de Guillain-Barr\u00e9 vs. miastenia grave<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Los s\u00edntomas del SGB y la MG difieren significativamente. Los del SGB suelen comenzar con hormigueo y entumecimiento en los pies y las piernas, que se extienden gradualmente a la parte superior del cuerpo y los brazos. La debilidad muscular puede progresar r\u00e1pidamente y, en ocasiones, incluso afectar los m\u00fasculos respiratorios, provocando par\u00e1lisis, que puede ser mortal. Otros s\u00edntomas tempranos y graves pueden incluir hormigueo o entumecimiento en las extremidades, problemas de visi\u00f3n, p\u00e9rdida de reflejos y dificultad para hablar, tragar y respirar. Estos s\u00edntomas comienzan r\u00e1pidamente y empeoran en cuesti\u00f3n de horas o d\u00edas.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Por otro lado, los s\u00edntomas de la MG pueden variar considerablemente seg\u00fan la gravedad y la localizaci\u00f3n de la debilidad muscular. La MG suele presentarse con debilidad muscular fluctuante que afecta m\u00fasculos espec\u00edficos que pueden controlarse voluntariamente. Los grupos musculares gravemente afectados por la MG incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">M\u00fasculos oculares y palpebrales que controlan el movimiento ocular. Aproximadamente <\/span><a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/myasthenia-gravis\/symptoms-causes\/syc-20352036\"><span style=\"font-weight: 400;\">El 50% de las personas que padecen miastenia gravis experimentan s\u00edntomas tempranos de problemas oculares.<\/span><\/a><span style=\"font-weight: 400;\"> como visi\u00f3n doble y uno o ambos p\u00e1rpados ca\u00eddos (llamado ptosis).&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">M\u00fasculos faciales y de la garganta que controlan las expresiones faciales. <\/span><a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/myasthenia-gravis\/symptoms-causes\/syc-20352036\"><span style=\"font-weight: 400;\">Alrededor de 15% de individuos<\/span><\/a><span style=\"font-weight: 400;\"> Las personas con miastenia gravis experimentan s\u00edntomas iniciales como cambios en las expresiones faciales, visi\u00f3n doble, dificultad para hablar o hablar arrastrando las palabras y dificultad para masticar y tragar.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Los m\u00fasculos del cuello y las extremidades generalmente controlan el movimiento de brazos, piernas, cuello, dedos y manos.<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">En algunos casos, los s\u00edntomas de la MG pueden ser potencialmente mortales, sobre todo si afectan los m\u00fasculos que controlan la respiraci\u00f3n. Adem\u00e1s, la debilidad en la MG tiende a empeorar con la actividad y a mejorar con el descanso.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Susceptible_Population\"><\/span><b>Poblaci\u00f3n Susceptible<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">El SGB puede afectar a cualquier persona, independientemente de su edad o sexo, pero es m\u00e1s com\u00fan en adultos y en la poblaci\u00f3n geri\u00e1trica. Por otro lado, la miastenia gravis (MG) puede afectar a personas de cualquier sexo, raza o etnia. Suele afectar a mujeres adultas menores de 40 a\u00f1os y a hombres mayores de 60.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onset_and_Progression\"><\/span><b>Inicio y progresi\u00f3n<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">El inicio y la progresi\u00f3n del s\u00edndrome de Guillain-Barr\u00e9 y la miastenia gravis tambi\u00e9n son diferentes. El SGB suele tener un inicio repentino y r\u00e1pido, con <a href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-symptoms\/\">s\u00edntomas<\/a> Alcanza su punto m\u00e1ximo en 2 o 3 semanas. Posteriormente, comienza a mejorar. El proceso de recuperaci\u00f3n puede durar varios meses o incluso a\u00f1os, dependiendo de la gravedad de la enfermedad. Algunas personas pueden experimentar s\u00edntomas persistentes, como debilidad, fatiga y dificultad para coordinar, incluso despu\u00e9s de la recuperaci\u00f3n.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Por el contrario, la MG puede tener un inicio m\u00e1s gradual, con <a href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/myasthenia-gravis\/myasthenia-gravis-symptoms-and-complications\/\">s\u00edntomas<\/a> Aparecen durante semanas o meses. La progresi\u00f3n de la MG puede ser impredecible y var\u00eda de persona a persona. Algunas personas pueden experimentar s\u00edntomas leves que se controlan bien con medicaci\u00f3n, mientras que otras pueden presentar s\u00edntomas graves que afectan significativamente su calidad de vida. En algunos casos, los s\u00edntomas pueden remitir por un tiempo, para luego reaparecer. Sin embargo, con el tratamiento adecuado, la mayor\u00eda de las personas con MG pueden controlar sus s\u00edntomas y llevar una vida normal.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-ade2993bba4e21b929463935c3dcf92c\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tInformaci\u00f3n sobre el tratamiento | Obtener autorizaci\u00f3n previa\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Factors_That_Trigger_GBS_and_MG\"><\/span><b>Factores que desencadenan el s\u00edndrome de Guillain-Barr\u00e9 y la miastenia gravis (MG)<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La causa exacta del SGB a\u00fan se desconoce, pero los investigadores creen que se desencadena por una infecci\u00f3n u otras enfermedades. En muchos casos, el SGB se desarrolla unos d\u00edas o semanas despu\u00e9s de una infecci\u00f3n respiratoria o gastrointestinal.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Otros factores que pueden desencadenar la aparici\u00f3n del s\u00edndrome de Guillain-Barr\u00e9 incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">El virus del Zika y la COVID-19<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Vacunaci\u00f3n, cirug\u00eda o trauma<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">En el caso de la MG, todav\u00eda se desconoce la causa exacta, pero se cree que est\u00e1 relacionada o es desencadenada por diversos factores ambientales y gen\u00e9ticos.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Treatment_Options_for_Guillain-Barre_Syndrome_vs_Myasthenia_Gravis\"><\/span><b>Opciones de tratamiento para el s\u00edndrome de Guillain-Barr\u00e9 frente a la miastenia grave<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Aunque no existe cura para el SGB y la MG, las estrategias de tratamiento eficaces pueden ayudar a mejorar los s\u00edntomas y acelerar la recuperaci\u00f3n en pacientes con estas afecciones. Al igual que los factores mencionados, los enfoques de tratamiento para el SGB y la MG son diferentes.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">El s\u00edndrome de Guillain-Barr\u00e9 generalmente se trata con terapia de inmunoglobulina o intercambio de plasma.&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><b><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-22864 size-full\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/ivig.jpg\" alt=\"IVIG for Guillain-barre syndrome\" width=\"420\" height=\"280\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/ivig.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/ivig-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/ivig-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/ivig-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/ivig-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/ivig-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/ivig-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/>Terapia con inmunoglobulina intravenosa<\/b><span style=\"font-weight: 400;\"> Implica la infusi\u00f3n de altas dosis de anticuerpos en el torrente sangu\u00edneo de los pacientes. Esta terapia ayuda a suprimir el sistema inmunitario y a reducir la inflamaci\u00f3n.&nbsp;<\/span><\/li>\n\n\n\n<li><b>Intercambio de plasma<\/b><span style=\"font-weight: 400;\"> Consiste en reemplazar el plasma sangu\u00edneo del paciente con plasma de un donante o un sustituto. Esto ayuda a eliminar los anticuerpos que atacan los nervios.<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">En el caso de la MG, generalmente se trata con medicamentos, cirug\u00eda y terapias.&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><b>Medicamentos <\/b><span style=\"font-weight: 400;\">Se utilizan f\u00e1rmacos inmunosupresores, como los inhibidores de la acetilcolinesterasa, para mejorar la se\u00f1alizaci\u00f3n nerviosa y reducir el ataque del sistema inmunitario a la uni\u00f3n neuromuscular.&nbsp;<\/span><\/li>\n\n\n\n<li><b><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560566\/\">Plasmaf\u00e9resis<\/a> y terapias de inmunoglobulina intravenosa<\/b><span style=\"font-weight: 400;\"> pueden beneficiar a los pacientes con MG ya que estas terapias eliminan los anticuerpos de la sangre.&nbsp;<\/span><\/li>\n\n\n\n<li><b>Timectom\u00eda<\/b><span style=\"font-weight: 400;\">, un procedimiento quir\u00fargico de extirpaci\u00f3n de la gl\u00e1ndula timo problem\u00e1tica, juega un papel en el reequilibrio del sistema inmunol\u00f3gico y la reducci\u00f3n de los s\u00edntomas.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">En conclusi\u00f3n, el s\u00edndrome de Guillain-Barr\u00e9 y la miastenia gravis son trastornos neurol\u00f3gicos autoinmunes y comparten algunas similitudes en sus s\u00edntomas y manifestaciones. Sin embargo, ambas enfermedades difieren en varios aspectos, como los mecanismos subyacentes, las causas, los patrones de debilidad muscular y los enfoques de tratamiento. Comprender la diferencia entre el SGB y la MG, as\u00ed como el diagn\u00f3stico temprano, pueden ayudar a mejorar los resultados de las personas afectadas por estas afecciones.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>El s\u00edndrome de Guillain-Barr\u00e9 (SGB) y la miastenia gravis (MG) son trastornos neurol\u00f3gicos autoinmunes que se producen cuando el sistema inmunitario ataca c\u00e9lulas sanas, como nervios y m\u00fasculos. Tanto el SGB como la MG son afecciones graves, pero poco frecuentes, que pueden causar discapacidades f\u00edsicas significativas e incluso provocar complicaciones potencialmente mortales si no se tratan.<\/p>","protected":false},"author":13,"featured_media":22863,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[20,10],"tags":[17],"class_list":["post-22861","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-guillain-barre-syndrome","category-myasthenia-gravis","tag-dr-saba-rassouli"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Guillain-Barr\u00e9 Syndrome vs. Myasthenia Gravis<\/title>\n<meta name=\"description\" content=\"Learn about the differences between Guillain-barr\u00e9 syndrome vs. Myasthenia Gravis. We cover the mechanism, symptoms, and treatment options.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guillain-Barr\u00e9 Syndrome vs. Myasthenia Gravis\" \/>\n<meta property=\"og:description\" content=\"Learn about the differences between Guillain-barr\u00e9 syndrome vs. Myasthenia Gravis. We cover the mechanism, symptoms, and treatment options.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-06T20:26:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-02T15:47:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/\"},\"author\":{\"name\":\"Dr. Saba Rassouli, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\"},\"headline\":\"Guillain-Barr\u00e9 Syndrome vs. Myasthenia Gravis\",\"datePublished\":\"2023-06-06T20:26:49+00:00\",\"dateModified\":\"2024-07-02T15:47:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/\"},\"wordCount\":1104,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/gbs-vs-mg.jpg\",\"keywords\":[\"Dr. Saba Rassouli\"],\"articleSection\":[\"Guillain-Barre Syndrome\",\"Myasthenia Gravis\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/\",\"name\":\"Guillain-Barr\u00e9 Syndrome vs. Myasthenia Gravis\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/gbs-vs-mg.jpg\",\"datePublished\":\"2023-06-06T20:26:49+00:00\",\"dateModified\":\"2024-07-02T15:47:06+00:00\",\"description\":\"Learn about the differences between Guillain-barr\u00e9 syndrome vs. Myasthenia Gravis. We cover the mechanism, symptoms, and treatment options.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/gbs-vs-mg.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/gbs-vs-mg.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Man with Guillain-Barre Syndrome holding hand\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/myasthenia-gravis\\\/guillain-barre-syndrome-vs-myasthenia-gravis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guillain-Barr\u00e9 Syndrome vs. Myasthenia Gravis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\",\"name\":\"Dr. Saba Rassouli, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"caption\":\"Dr. Saba Rassouli, PharmD\"},\"description\":\"Dr. Saba Rassouli, PharmD was born and raised in Iran. She received her pharmacy degree from Marshall B. Ketchum University in 2022, where she graduated cum laude. The most rewarding part of her job is having the opportunity to care for each patient as if they were family and hearing about how happy and satisfied they are with the services provided by AmeriPharma. In her free time, she likes to go on walks, read books, and try different restaurants and foods.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/saba-rassouli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"S\u00edndrome de Guillain-Barr\u00e9 vs. Miastenia Gravis","description":"Conozca las diferencias entre el s\u00edndrome de Guillain-Barr\u00e9 y la miastenia grave. Abordamos el mecanismo, los s\u00edntomas y las opciones de tratamiento.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"es_MX","og_type":"article","og_title":"Guillain-Barr\u00e9 Syndrome vs. Myasthenia Gravis","og_description":"Learn about the differences between Guillain-barr\u00e9 syndrome vs. Myasthenia Gravis. We cover the mechanism, symptoms, and treatment options.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-06-06T20:26:49+00:00","article_modified_time":"2024-07-02T15:47:06+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg","type":"image\/jpeg"}],"author":"Dr. Saba Rassouli, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Saba Rassouli, PharmD","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/"},"author":{"name":"Dr. Saba Rassouli, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01"},"headline":"Guillain-Barr\u00e9 Syndrome vs. Myasthenia Gravis","datePublished":"2023-06-06T20:26:49+00:00","dateModified":"2024-07-02T15:47:06+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/"},"wordCount":1104,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg","keywords":["Dr. Saba Rassouli"],"articleSection":["Guillain-Barre Syndrome","Myasthenia Gravis"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/","url":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/","name":"S\u00edndrome de Guillain-Barr\u00e9 vs. Miastenia Gravis","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg","datePublished":"2023-06-06T20:26:49+00:00","dateModified":"2024-07-02T15:47:06+00:00","description":"Conozca las diferencias entre el s\u00edndrome de Guillain-Barr\u00e9 y la miastenia grave. Abordamos el mecanismo, los s\u00edntomas y las opciones de tratamiento.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg","width":1280,"height":853,"caption":"Man with Guillain-Barre Syndrome holding hand"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/guillain-barre-syndrome-vs-myasthenia-gravis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Guillain-Barr\u00e9 Syndrome vs. Myasthenia Gravis"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01","name":"Dra. Saba Rassouli, Farmac\u00e9utica","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","caption":"Dr. Saba Rassouli, PharmD"},"description":"La Dra. Saba Rassouli, doctora en farmacia, naci\u00f3 y creci\u00f3 en Ir\u00e1n. Obtuvo su t\u00edtulo en farmacia en la Universidad Marshall B. Ketchum en 2022, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es tener la oportunidad de atender a cada paciente como si fuera de su familia y escuchar lo contentos y satisfechos que est\u00e1n con los servicios de AmeriPharma. En su tiempo libre, le gusta pasear, leer y probar diferentes restaurantes y comidas.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"uagb_comment_info":0,"uagb_excerpt":"Guillain barr\u00e9 syndrome (GBS) and Myasthenia gravis (MG) are neurological autoimmune disorders that occur when the body's immune system starts attacking healthy cells, such as nerves and muscles. GBS and MG both are actually severe but rare conditions that can cause significant physical impairments and even lead to life-threatening complications if left untreated.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/06\/gbs-vs-mg.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/guillain-barre-syndrome\/\" rel=\"category tag\">Guillain-Barre Syndrome<\/a> <a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/myasthenia-gravis\/\" rel=\"category tag\">Myasthenia Gravis<\/a>","rttpg_excerpt":"Guillain barr\u00e9 syndrome (GBS) and Myasthenia gravis (MG) are neurological autoimmune disorders that occur when the body's immune system starts attacking healthy cells, such as nerves and muscles. GBS and MG both are actually severe but rare conditions that can cause significant physical impairments and even lead to life-threatening complications if left untreated.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/22861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=22861"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/22861\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/22863"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=22861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=22861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=22861"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}